Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Protection Against Marburg Virus Using a Recombinant VSV-Vaccine Depends on T and B Cell Activation.

Marzi A, Menicucci AR, Engelmann F, Callison J, Horne EJ, Feldmann F, Jankeel A, Feldmann H, Messaoudi I.

Front Immunol. 2019 Jan 22;9:3071. doi: 10.3389/fimmu.2018.03071. eCollection 2018.

2.

The contribution of endogenous glutamatergic input in the ventral respiratory column to respiratory rhythm.

Cook-Snyder DR, Miller JR, Navarrete-Opazo AA, Callison JJ, Peterson RC, Hopp FA, Stuth EAE, Zuperku EJ, Stucke AG.

Respir Physiol Neurobiol. 2019 Feb;260:37-52. doi: 10.1016/j.resp.2018.11.011. Epub 2018 Nov 28.

PMID:
30502519
3.

Somatostatin receptor 2 signaling promotes growth and tumor survival in small-cell lung cancer.

Lehman JM, Hoeksema MD, Staub J, Qian J, Harris B, Callison JC, Miao J, Shi C, Eisenberg R, Chen H, Chen SC, Massion PP.

Int J Cancer. 2019 Mar 1;144(5):1104-1114. doi: 10.1002/ijc.31771. Epub 2018 Oct 9.

PMID:
30152518
4.

A VSV-based Zika virus vaccine protects mice from lethal challenge.

Emanuel J, Callison J, Dowd KA, Pierson TC, Feldmann H, Marzi A.

Sci Rep. 2018 Jul 23;8(1):11043. doi: 10.1038/s41598-018-29401-x.

5.

Structural behaviour of copper chloride catalysts during the chlorination of CO to phosgene.

Guan S, Davies PR, Gibson EK, Lennon D, Rossi GE, Winfield JM, Callison J, Wells PP, Willock DJ.

Faraday Discuss. 2018 Sep 3;208(0):67-85. doi: 10.1039/c8fd00005k.

PMID:
29850700
6.

Lethal Zika Virus Disease Models in Young and Older Interferon α/β Receptor Knock Out Mice.

Marzi A, Emanuel J, Callison J, McNally KL, Arndt N, Chadinha S, Martellaro C, Rosenke R, Scott DP, Safronetz D, Whitehead SS, Best SM, Feldmann H.

Front Cell Infect Microbiol. 2018 Apr 11;8:117. doi: 10.3389/fcimb.2018.00117. eCollection 2018.

7.

Radiation-induced changes in intestinal and tissue-nonspecific alkaline phosphatase: implications for recovery after radiation therapy.

Rentea RM, Lam V, Biesterveld B, Fredrich KM, Callison J, Fish BL, Baker JE, Komorowski R, Gourlay DM, Otterson MF.

Am J Surg. 2016 Oct;212(4):602-608. doi: 10.1016/j.amjsurg.2016.06.005. Epub 2016 Jul 18.

PMID:
27501776
8.

Development and Characterization of Broadly Cross-reactive Monoclonal Antibodies Against All Known Ebolavirus Species.

Hernandez H, Marceau C, Halliday H, Callison J, Borisevich V, Escaffre O, Creech J, Feldmann H, Rockx B.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S410-3. doi: 10.1093/infdis/jiv209. Epub 2015 May 21.

9.

Soluble Glycoprotein Is Not Required for Ebola Virus Virulence in Guinea Pigs.

Hoenen T, Marzi A, Scott DP, Feldmann F, Callison J, Safronetz D, Ebihara H, Feldmann H.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S242-6. doi: 10.1093/infdis/jiv111. Epub 2015 May 9.

10.

A novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivity.

Watt A, Moukambi F, Banadyga L, Groseth A, Callison J, Herwig A, Ebihara H, Feldmann H, Hoenen T.

J Virol. 2014 Sep;88(18):10511-24. doi: 10.1128/JVI.01272-14. Epub 2014 Jun 25.

11.

A novel Ebola virus expressing luciferase allows for rapid and quantitative testing of antivirals.

Hoenen T, Groseth A, Callison J, Takada A, Feldmann H.

Antiviral Res. 2013 Sep;99(3):207-13. doi: 10.1016/j.antiviral.2013.05.017. Epub 2013 Jun 7.

12.

Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin.

Falzarano D, de Wit E, Martellaro C, Callison J, Munster VJ, Feldmann H.

Sci Rep. 2013;3:1686. doi: 10.1038/srep01686.

13.

The state of molecular biomarkers for the early detection of lung cancer.

Hassanein M, Callison JC, Callaway-Lane C, Aldrich MC, Grogan EL, Massion PP.

Cancer Prev Res (Phila). 2012 Aug;5(8):992-1006. doi: 10.1158/1940-6207.CAPR-11-0441. Epub 2012 Jun 11. Review.

14.

A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challenge.

Bossart KN, Geisbert TW, Feldmann H, Zhu Z, Feldmann F, Geisbert JB, Yan L, Feng YR, Brining D, Scott D, Wang Y, Dimitrov AS, Callison J, Chan YP, Hickey AC, Dimitrov DS, Broder CC, Rockx B.

Sci Transl Med. 2011 Oct 19;3(105):105ra103. doi: 10.1126/scitranslmed.3002901.

15.

Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy.

Marzi A, Ebihara H, Callison J, Groseth A, Williams KJ, Geisbert TW, Feldmann H.

J Infect Dis. 2011 Nov;204 Suppl 3:S1066-74. doi: 10.1093/infdis/jir348.

16.

Role of the Yersinia pestis Ail protein in preventing a protective polymorphonuclear leukocyte response during bubonic plague.

Hinnebusch BJ, Jarrett CO, Callison JA, Gardner D, Buchanan SK, Plano GV.

Infect Immun. 2011 Dec;79(12):4984-9. doi: 10.1128/IAI.05307-11. Epub 2011 Oct 3.

17.

Clinical outcome of henipavirus infection in hamsters is determined by the route and dose of infection.

Rockx B, Brining D, Kramer J, Callison J, Ebihara H, Mansfield K, Feldmann H.

J Virol. 2011 Aug;85(15):7658-71. doi: 10.1128/JVI.00473-11. Epub 2011 May 18.

18.

Somatostatin Receptors in Lung Cancer: From Function to Molecular Imaging and Therapeutics.

Callison JC Jr, Walker RC, Massion PP.

J Lung Cancer. 2011;10(2):69-76.

19.

A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment.

Rockx B, Bossart KN, Feldmann F, Geisbert JB, Hickey AC, Brining D, Callison J, Safronetz D, Marzi A, Kercher L, Long D, Broder CC, Feldmann H, Geisbert TW.

J Virol. 2010 Oct;84(19):9831-9. doi: 10.1128/JVI.01163-10. Epub 2010 Jul 21.

20.

Loss of a biofilm-inhibiting glycosyl hydrolase during the emergence of Yersinia pestis.

Erickson DL, Jarrett CO, Callison JA, Fischer ER, Hinnebusch BJ.

J Bacteriol. 2008 Dec;190(24):8163-70. doi: 10.1128/JB.01181-08. Epub 2008 Oct 17.

21.

Characterization and expression analysis of the groESL operon of Bartonella bacilliformis.

Callison JA, Battisti JM, Sappington KN, Smitherman LS, Minnick MF.

Gene. 2005 Oct 10;359:53-62.

22.

Clinical outcome at a minimum of five years after reconstruction of the anterior cruciate ligament.

Spindler KP, Warren TA, Callison JC Jr, Secic M, Fleisch SB, Wright RW.

J Bone Joint Surg Am. 2005 Aug;87(8):1673-9.

PMID:
16085604
23.

An anti-CD45RO immunotoxin kills HIV-latently infected cells from individuals on HAART with little effect on CD8 memory.

Saavedra-Lozano J, Cao Y, Callison J, Sarode R, Sodora D, Edgar J, Hatfield J, Picker L, Peterson D, Ramilo O, Vitetta ES.

Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2494-9.

24.

Pop bottle explosions.

Bergeson PS, Sehring SA, Callison JR.

JAMA. 1977 Sep 5;238(10):1048-9.

PMID:
577946
25.

Plastic management of extensive vulvar defects.

Julian CG, Callison J, Woodruff JD.

Obstet Gynecol. 1971 Aug;38(2):193-8. No abstract available.

PMID:
4327054
26.

The surgical treatment of transsexual patients. Limitations and indications.

Edgerton MT, Knorr NJ, Callison JR.

Plast Reconstr Surg. 1970 Jan;45(1):38-46. No abstract available.

PMID:
4902840
27.

Role of mesotenon in tendon blood supply.

Colville J, Callison JR, White WL.

Plast Reconstr Surg. 1969 Jan;43(1):53-60. No abstract available.

PMID:
5765083
28.

Fibro-fatty proliferation of the median nerve.

Callison JR, Thoms OJ, White WL.

Plast Reconstr Surg. 1968 Nov;42(5):403-13. No abstract available.

PMID:
4301740
29.

II. Tumors of the Carotid Body.

Callison JG, Mackenty JE.

Ann Surg. 1913 Dec;58(6):740-65. No abstract available.

30.

A diluting Fluid for Standardization of Vaccines with the Hemocytometer.

Callison JG.

J Med Res. 1912 Nov;27(2):225-7. No abstract available.

Supplemental Content

Loading ...
Support Center